Chemotherapy vs. HSCT
Thirteen patients went on to receive stem cell transplant form fully matched, HLA identical health siblings as donors, while chemotherapy alone was administered in rest of the patients . From the transplanted group of patients all of them achieved full-engraftment, however four patients relapsed, while three patients died in remission due to toxicity related to the transplant and could be characterised as transplant related mortality. Out of the 18 patients who received chemotherapy, four patients have relapsed, while 11 patients died due to treatment – related toxicities. When comparing OS at 3 -years who proceeded to receive HSCT vs. chemotherapy (61.4% vs. 27.3%) no statistical significance was observed as demonstrated in Figure 2